Table 3.
Nominally significant associations of polymorphisms with rate of decline of lung function in the LHS cohort
| Genotype Counts |
Unadjusted Analysis |
Adjusted Analysis‡ |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| SNP | Gene | Genotype | Nondecliners | Fast Decliners | P Value* | Permuted P Value† | Odds Ratio | 95% Confidence Interval | P Value |
| rs9573956 | IRG1 | AA | 6 | 0 | 0.0006 | 0.0009 | 0.443 | 0.267–0.735 | 0.0016 |
| AG | 48 | 25 | |||||||
| GG | 231 | 237 | |||||||
| rs3092794 | NCOA3 | AA | 61 | 41 | 0.0351 | 0.0318 | 0.683 | 0.525–0.888 | 0.0044 |
| AG | 153 | 130 | |||||||
| GG | 71 | 89 | |||||||
| rs6125042 | NCOA3 | CC | 5 | 8 | 0.0517 | 0.0555 | 1.646 | 1.143–2.371 | 0.0074 |
| TC | 53 | 68 | |||||||
| TT | 227 | 184 | |||||||
| rs9565305 | IRG1 | GG | 5 | 0 | 0.0043 | 0.0030 | 0.522 | 0.325–0.840 | 0.0074 |
| TG | 51 | 31 | |||||||
| TT | 229 | 231 | |||||||
| rs11085735 | KEAP1 | GG | 261 | 223 | 0.0292 | 0.0496 | 2.043 | 1.206–3.461 | 0.0079 |
| TG | 23 | 34 | |||||||
| TT | 1 | 5 | |||||||
| rs17708487 | BACH2 | AA | 168 | 134 | 0.1657 | 0.1628 | 1.478 | 1.102–1.983 | 0.0091 |
| AG | 99 | 108 | |||||||
| GG | 16 | 19 | |||||||
| rs8176199 | BRCA1 | AA | 170 | 140 | 0.0348 | 0.0342 | 1.513 | 1.097–2.088 | 0.0116 |
| AC | 82 | 93 | |||||||
| CC | 8 | 17 | |||||||
| rs634534 | FOSL1 | AA | 59 | 45 | 0.0861 | 0.0872 | 0.733 | 0.567–0.948 | 0.0179 |
| AG | 145 | 121 | |||||||
| GG | 79 | 96 | |||||||
| rs16882297 | BACH2 | CC | 262 | 226 | 0.0369 | 0.0345 | 1.941 | 1.105–3.407 | 0.0209 |
| GC | 23 | 34 | |||||||
| GG | 0 | 2 | |||||||
| rs5758223 | EP300 | AA | 160 | 129 | 0.0648 | 0.0610 | 1.366 | 1.039–1.796 | 0.0255 |
| AG | 107 | 103 | |||||||
| GG | 18 | 30 | |||||||
| rs4722029 | GNA12 | CC | 10 | 14 | 0.0526 | 0.0555 | 1.427 | 1.043–1.952 | 0.0262 |
| TC | 77 | 92 | |||||||
| TT | 197 | 156 | |||||||
| rs20552 | EP300 | AA | 123 | 104 | 0.0634 | 0.0633 | 1.333 | 1.033–1.720 | 0.0273 |
| TA | 130 | 110 | |||||||
| TT | 32 | 48 | |||||||
| rs1915919 | PCAF | CC | 114 | 77 | 0.0281 | 0.0295 | 1.338 | 1.030–1.739 | 0.0292 |
| TC | 133 | 139 | |||||||
| TT | 38 | 46 | |||||||
| rs176713 | BACH2 | AA | 230 | 192 | 0.1166 | 0.1238 | 1.549 | 1.042–2.303 | 0.0305 |
| AG | 53 | 67 | |||||||
| GG | 2 | 3 | |||||||
| rs6808352 | PCAF | GG | 17 | 33 | 0.0242 | 0.0221 | 1.358 | 1.029–1.792 | 0.0307 |
| TG | 129 | 114 | |||||||
| TT | 139 | 115 | |||||||
| rs427967 | NCOA3 | CC | 174 | 184 | 0.0777 | 0.0819 | 0.700 | 0.504–0.971 | 0.0325 |
| TC | 100 | 70 | |||||||
| TT | 11 | 8 | |||||||
| rs9344981 | BACH2 | CC | 108 | 83 | 0.1763 | 0.1780 | 1.332 | 1.023–1.736 | 0.0334 |
| TC | 140 | 133 | |||||||
| TT | 37 | 46 | |||||||
| rs4951627 | ATF3 | CC | 16 | 7 | 0.0544 | 0.0552 | 0.708 | 0.514–0.976 | 0.0349 |
| CG | 92 | 70 | |||||||
| GG | 177 | 185 | |||||||
| rs10183914 | NFE2L2 | CC | 115 | 121 | 0.3724 | 0.3840 | 0.749 | 0.571–0.982 | 0.0365 |
| TC | 134 | 113 | |||||||
| TT | 36 | 28 | |||||||
| rs9565304 | IRG1 | AA | 215 | 215 | 0.0608 | 0.0625 | 0.656 | 0.442–0.974 | 0.0365 |
| AG | 62 | 45 | |||||||
| GG | 8 | 2 | |||||||
| rs3846991 | GNA12 | CC | 31 | 37 | 0.1178 | 0.1220 | 1.315 | 1.013–1.707 | 0.0394 |
| CG | 120 | 124 | |||||||
| GG | 134 | 101 | |||||||
| rs831172 | IRG1 | AA | 93 | 99 | 0.2760 | 0.2760 | 0.760 | 0.584–0.990 | 0.0422 |
| AG | 141 | 126 | |||||||
| GG | 51 | 36 | |||||||
| rs2143491 | NCOA3 | CC | 115 | 127 | 0.1535 | 0.1520 | 0.758 | 0.579–0.993 | 0.0444 |
| TC | 134 | 110 | |||||||
| TT | 35 | 25 | |||||||
The odds ratios are for a rapid rate of decline and the reference is the wild-type homozygote genotype. SNP, single nucleotide polymorphism.
Likelihood ratio χ2-test.
P value using 10,000 random permutations.
Association under an additive genetic model adjusted for age, sex, pack-years of smoking, and recruitment center.